# A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors

> **NCT02558140** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 120 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **BIOLOGICAL:** RO6874813
- **BIOLOGICAL:** RO6874813

## Key facts

- **NCT ID:** NCT02558140
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-11
- **Primary completion:** 2017-11-06
- **Final completion:** 2017-11-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558140, "A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02558140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*